Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12887-021-02812-y http://scihub22266oqcxt.onion/10.1186/s12887-021-02812-y 34353302!8338201!34353302     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34353302&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       BMC+Pediatr 2021 ; 21 (1): 333 Nephropedia Template TP {{tp|p=34353302|t=2021. New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report |pdf=|usr=}}{{34353302}} gab.com Text New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report JO: BMC Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34353302 #FOAvip BACKGROUND: SARS-CoV-2 has been found to be exquisitely adept at triggering autoimmunity and multiple new onset autoimmune diseases have been described as a post-infectious complication of COVID-19 infection in the adult population. Less has been described in the pediatric population, as infections are more likely to be asymptomatic and less severe. This case reports a previously healthy adolescent patient with new onset antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) diagnosed in the setting of acute COVID-19 infection. CASE PRESENTATION: A previously healthy adolescent male was diagnosed with COVID-19 pneumonia after presenting with infectious symptoms of fever, cough, congestion, and shortness of breath. After worsening of disease, he was found to have pulmonary nodules, atypical for COVID-19. Further imaging and laboratory workup showed elevated inflammatory markers, negative infectious testing, and positive antineutrophil cytoplasmic antibodies (ANCA) diagnostic for AAV. He was treated with pulse dose steroids followed by a prolonged taper and rituximab. Symptoms resolved and laboratory abnormalities improved over time. At six-month follow-up, lesions were much improved, laboratory markers were within normal limits, and patient remained asymptomatic off medications. CONCLUSIONS: This case is one of the first in the pediatric population to describe new onset AAV presenting with an acute, symptomatic COVID-19 infection. There is increasing evidence for COVID-19 induced autoimmunity in the pediatric population and pediatric care providers should be on high alert for new onset autoimmune disease in children afflicted by COVID-19. Twit Text FOAVip New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report ????BMC Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34353302 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34353302 #FOAvip English Wikipedia <ref>{{Cite pmid|34353302}}</ref> New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report #MMPMID34353302 Reiff DD; Meyer CG; Marlin B; Mannion ML BMC Pediatr 2021[Aug]; 21 (1): 333 PMID34353302show ga BACKGROUND: SARS-CoV-2 has been found to be exquisitely adept at triggering autoimmunity and multiple new onset autoimmune diseases have been described as a post-infectious complication of COVID-19 infection in the adult population. Less has been described in the pediatric population, as infections are more likely to be asymptomatic and less severe. This case reports a previously healthy adolescent patient with new onset antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) diagnosed in the setting of acute COVID-19 infection. CASE PRESENTATION: A previously healthy adolescent male was diagnosed with COVID-19 pneumonia after presenting with infectious symptoms of fever, cough, congestion, and shortness of breath. After worsening of disease, he was found to have pulmonary nodules, atypical for COVID-19. Further imaging and laboratory workup showed elevated inflammatory markers, negative infectious testing, and positive antineutrophil cytoplasmic antibodies (ANCA) diagnostic for AAV. He was treated with pulse dose steroids followed by a prolonged taper and rituximab. Symptoms resolved and laboratory abnormalities improved over time. At six-month follow-up, lesions were much improved, laboratory markers were within normal limits, and patient remained asymptomatic off medications. CONCLUSIONS: This case is one of the first in the pediatric population to describe new onset AAV presenting with an acute, symptomatic COVID-19 infection. There is increasing evidence for COVID-19 induced autoimmunity in the pediatric population and pediatric care providers should be on high alert for new onset autoimmune disease in children afflicted by COVID-19. |*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications/diagnosis/drug therapy[MESH] |*COVID-19[MESH] |*Infections[MESH] |Adolescent[MESH] |Adult[MESH] |Antibodies, Antineutrophil Cytoplasmic[MESH] |Child[MESH] |Humans[MESH] |Male[MESH]New onset ANCA-associated vasculitis in an adolescent during an acute (epmc).pdf DeepDyve Pubget Overpricing